Wockhardt Exits US Generics Pharma Business To Focus On Innovation-Driven Areas; Details Here
Last Updated:July 11, 2025, 17:57 is Wockhardt says its US generics business has been loss-making for several years, incurring a loss of nearly $8 million in FY25 alone. Ahead of the announcement, shares of Wockhardt Ltd closed 3.5% higher at Rs 1,756 apiece on the BSE. Wockhardt Ltd on Friday announced a strategic exit from…